ELN and aneurysm: Nosoudi et al. described the use of anti-elastin nanoparticles loaded with batimastat, a hydroamate-based MMP inhibitor, to determine its feasibility as an intravascular therapy that would traffic to the aneurysm site by targeting elastin in a rat CaCl2 model (123).